The Execution Problem Inside 340B Compliance

Contributed by SME: Valerie Bandy, PharmD, Vice President, Pharmacy Solutions, Tecsys The 340B Drug Pricing program has been under a microscope lately. Senator Bill Cassidy’s proposals to tighten oversight have once again put the program’s future in question, and pharmaceutical manufacturers have begun withdrawing discounts from hospitals that don’t meet their own requirements.  This is […]

Mastering the Momentum: Why Cash Flow, Not Margin, Dictates Pharmacy Success

independent pharmacy

Contributed by SME, Mike Bollinger, Director of Pharmacy, Live Oak Bank The Delicate Balance: Inside Pharmacy Cash FlowThe cash flow of an independent pharmacy is clunky. To the untrained eye, it looks highly unpredictable and scary, but to someone who understands the flow of funds, it is incredibly telling.The daily operations of a pharmacy rely […]

Building a Modern Data Integrity Assessment Program for 503B Compounding Facilities

SME_503B

Contributed by SME: Diane K Gates, President, CenPharma 503B outsourcing facilities sit at a difficult intersection. They operate with the pace and variability of a hospital pharmacy, but they are held to CGMP expectations that increasingly resemble those applied to large commercial drug product manufacturers. Nowhere is this tension more visible than in data integrity. […]

AI May Improve Pharmacy Operations, But Brand Is Still How Pharmacies Grow

Pharmacy Brand

Contributed by SME: Richard Waithe, PharmD, COO, Pyrls Why pharmacies should pair operational efficiency with local marketing, community trust, and a modern content strategy. Right now, it feels like every conversation in pharmacy starts and ends with AI. The tools are improving quickly, and many of them are genuinely useful. AI can help you streamline […]

Why the 340B Rebate Debate Matters

340B_rebates

Contributed by Steven Miller, Vice President of Pharmacy and Education for 340B Health For those who may not follow the 340B drug pricing program closely, what is the 340B rebate issue and why is it receiving so much attention?The 340B drug pricing program has always been built on upfront discounts. Hospitals and other covered entities […]

A Tale of Two Pharmacists: Lesson in Pharmacy Leadership

Tale of Two RPh

Contributed by SME: Jerry Fu, PharmD, PCC, Career and Leadership Coach, Acaria Health The names are made up, but the story is real. Ken and Sarah work for the same staffing agency. Both were called up to cover shifts at a pharmacy that needed extra help for their staff. Each of them had the opportunity […]

The Future of Infusion Pharmacy

IV_Infusion

Driving Clinical Excellence Across Hospitals & Health Systems Contributed by Samantha Denson, PharmD, RPh, Global Medical Affairs Fellow, Abbott What role does infusion pharmacy play in the modern hospital or health system?Infusion pharmacy is the backbone of patient care in hospitals and health systems. Every sterile preparation, compounded medication, and infusion delivered to the bedside […]

Specialty Pharmacy Outlook 2026

Specialty Pharmacy

By Sheila M. Arquette, RPhPresident & CEO, National Association of Specialty Pharmacy Ensuring patients have access to the medications they need from the specialty pharmacy of their choosing and championing protections essential to the long-term sustainability of the specialty pharmacy business model have always been top priorities for NASP. The Inflation Reduction Act’s (IRA) drug […]

PBM Reform Signed Into Law: What Pharmacies Need to Know

Government

By, Steve Postal, Senior Director, Policy and Regulatory Affairs at National Community Pharmacists Association (NCPA), and Editorial Director of American Society for Pharmacy Law (ASPL) On February 3, President Trump signed into law that reform pharmacy benefit manager (PBM) practices in Medicare Part D. The law requires, among other things, the Department of Health and […]

Pharmacies Concerned with the Medicare Drug Price Negotiation Program

Pharmacies Concerned with MDPNP

Contributed by, Steve Postal, Senior Director, Policy and Regulatory Affairs at National Community Pharmacists Association (NCPA), and Editorial Director of American Society for Pharmacy Law (ASPL) Under the Medicare Drug Price Negotiation Program (MDPNP), starting this month, the secretary of the Department of Health and Human Services (HHS) has negotiated pricing for the 10 top-spend […]

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from Pharmacies Concerned with the Medicare Drug Price Negotiation Program

Name
Address
Subscribe